HPHA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Heidelberg Pharma AG

Watchlist Manager

Watchlist

Price: 2.46 EUR -3.53% Market Closed

Market Cap: €115.1m

	Heidelberg Pharma AG XETRA:HPHA	DE
	J&T Global Express Ltd F:J92	CN
R	Rockfire Resources PLC F:P2P	UK
C	Cushman & Wakefield PLC F:2IY	UK
	Evolution AB (publ) STO:EVO	SE
	Investor AB F:IVS	SE
C	Champion Pacific Indonesia Tbk PT SWB:IUD	ID
B	Boyd Gaming Corp F:BO5	US
	Jackson Financial Inc F:8WF	US
P	Pennantpark Investment Corp F:12P	US
	Pebblebrook Hotel Trust NYSE:PEB	US
N	Nextdoor Holdings Inc NYSE:KIND	US
N	Nuvalent Inc NASDAQ:NUVL	US
A	Anthem Inc F:A58	US
U	Unisys Corp DUS:USY1	US
F	Fast Retailing Co Ltd OTC:FRCOY	JP
A	Avex Inc F:AX8	JP
	Dell Technologies Inc NYSE:DELL	US

Profitability Summary

Heidelberg Pharma AG's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

81%

Strong 3Y Average Gross Margin

77%

Gross Margin is Increasing

62% > 81%

Negative Operating Margin

-3 145%

Negative 3Y Average Operating Margin

-600%

Declining Operating Margin

-245% > -3 145%

Negative Net Margin

-2 901%

Negative 3Y Average Net Margin

-560%

Declining Net Margin

-247% > -2 901%

Negative Free Cash Flow Margin

-2 178%

Negative 3Y Average Free Cash Flow Margin

-623%

Declining Free Cash Flow Margin

-322% > -2 178%

Negative ROE

-424%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-120%

Declining ROIC

-178% > -225%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.